Assistant Professor
Division of Gynecologic Oncology
Board eligible Gynecologic Oncologist
Contact Information
| Mailing Address: |
Division of Gynecologic Oncology |
| Academic Phone: | 415-885-7561 |
| Academic Fax: | 415-885-3586 |
Research/Clinical Interests
Dr. Andrea Nanez is a board certified gynecologic oncologist. She provides care for women with cervical, uterine, ovarian, and vulvar cancer. Both surgical and medical care, including treatment with chemotherapy. Her research focuses on disparities in clinical trials, including how to improvement patient understanding of clinical trials. She is committed to addressing disparities improving equity within the field gynecologic oncology through research.
Education/Training
| Year | Institution & Location | Degree | Field of Study |
|---|---|---|---|
| 2013 | University of New Mexico, Albuquerque | B.A. | Biology |
| 2017 | University of New Mexico School of Medicine | M.D. | Medicine |
| 2021 | Kaiser Permanente San Francisco | Residency |
Obstetrics & Gynecology |
| 2024 | University of California Los Angeles | Fellowship |
Gynecologic Oncology |
Achievements & Recognition
| Year | Major Honors |
|---|---|
| 2020 |
Kaiser Permanente San Francisco UCSF Outstanding Award in Medical Student Education SGO Resident Award Academy of Medical Educators Resident Research Award SASGOG Resident Award ASCCP Resident Award |
Selected Publications
1. Stewart CE, Nañez A, Ayoola-Adeola M, Chase D. Reducing health disparities in endometrial cancer care in 2024. Curr Opin Obstet Gynecol. 2024 Feb 1;36(1):18-22. PMID: 37902961
2. Velez MA, Glenn BA, Garcia-Jimenez M, Cummings AL, Lisberg A, Nañez A, et al.Consent document translation expense hinders inclusive clinical trial enrolment.Nature. 2023;620(7975):855-862. PMID: 37532930
3. Nañez A, Stram DA, Bethan Powell C, Garcia C. Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer. Gynecol Oncol Rep. 2022;39:100899. PMID: 34917730
4. Nañez A, Stram DA, Garcia C, Powell CB. Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system. Gynecol Oncol. 2021 Jul 27:S0090-8258(21)00600-4. doi:10.1016/j.ygyno.2021.07.034. PMID: 34330534
5. Mayfield JJ, Ball EM, Tillery KA, Crandall C, Dexter J, Winer JM, Bosshardt ZM, Welch JH, Dolan E, Fancovic ER, Nañez A, et al. Beyond Men, Women, or Both: A. Comprehensive, LGBTQ-Inclusive, Implicit-Bias-Aware, Standardized- Patient-Based Sexual History Taking Curriculum. MedEdPORTAL. 2017, Sep; 13(10634): 1-9. PMID: 30800835.